Caphaven Partners, a London-based private equity firm, has acquired a significant minority stake in Deutsche Prüfservice (DPS), a German electrical testing provider. Terms of the transaction have not been disclosed. Founded in 2015 by Christoph Ulrich Püttmann and based in Erkrath near Dusseldorf, DPS has rapidly grown to become one
Align Capital Partners (ACP) has completed the majority acquisition of Barrow-Agee Laboratories, (Barrow-Agee), a niche market leader in the food safety and testing industry. This represents ACP’s second acquisition of the quarter, and the fourth platform company acquisition since the firm’s first fund closed in September 2016. Barrow-Agee is
ESPIRA Investments (ESPIRA), a newly established private equity firm focused on growth capital investments in small and medium size enterprises based in Central Europe, has held the first closing of its fund ESPIRA Fund I, which has a target fund size of EUR30 million. An element of ESPIRA’s strategy is
Northleaf Capital Partners (Northleaf) has held the final closing of its global private credit fund, Northleaf Private Credit I (NPC I), with more than USD670 million in commitments from institutional investors. Including recent closings of its private equity and infrastructure funds, Northleaf now manages more than USD10 billion in commitments across its global private
The SoftBank Vision Fund has agreed to invest USD450 million in Compass, a real estate technology company. This investment will bring the total capital raised to USD775 million. Compass will use the capital to expand to every major US city and increase its investment in technology to further empower Compass
Clearwater International UK has advised market leading tile specialist Domus on its sale to Europe’s largest floor coverings distributor Headlam plc. With over 50 years’ experience, Domus provides specification consultancy and supplies tiles, engineered flooring and other hard surfaces to premium commercial and residential construction projects in London and the
Epidarex Capital (Epidarex) portfolio company Harpoon Medical (Harpoon), a pioneer in beating-heart repair for degenerative mitral regurgitation (DMR), has been acquired by Edwards Lifesciences for up to USD250 million. Under the terms of the merger agreement, Edwards paid USD100 million in cash for Harpoon at closing on 1 December, 2017
Abacus Group has added 72 new client firms through the first three quarters of 2017 along with a host of platform and cybersecurity enhancements, and a new solution specifically for small and start-up funds. Chris Grandi, CEO of Abacus Group, says the company has surpassed 100 employees as it completes
Churchill Asset Management (Churchill), a provider of senior and unitranche debt financing to middle market companies, has closed its second structured debt investment offering, a USD340 million collateralised loan obligation fund (CLO) named TIAA Churchill Middle Market CLO II Ltd. This follows TIAA Churchill Middle Market CLO I Ltd, a
IWSC Group has rebranded as The Conversion Fund in a move the firm says more accurately reflects the nature of the company as a private investment vehicle, partnering with entrepreneurs and innovative management teams to drive sustainable value. With expertise in acquiring, incubating and growing businesses that span sectors in
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
